Introduction
Chronic fatigue, defined as substantial fatigue lasting for more than six months, affects up to 18 % of the adult population in Western countries [1] . In adolescents, about 20 % of girls and 6.5 % of boys report to have been severely fatigued during the last month [2] . If fatigue is unexplained, long lasting, disabling and accompanied by musculoskeletal pain, orthostatic intolerance, cognitive problems, post exertional malaise and other symptoms, the patient may fulfill one of the case-definitions of Chronic Fatigue Syndrome (CFS) [3] . These casedefinitions are based solely on different constellations of patient-reported symptoms, as no biomarker has been identified. CFS has two age peaks in incidence, the first during adolescence and the second from 30 to 39 years [4] , and female-to-male ratio varies from 2:1 to 5:1 across studies. The prevalence of CFS among adolescents is estimated at 0.1 to 1.9 %, depending on the applied case definition [5] ; anyhow, it constitutes one of the most significant health problems among young people.
The pathophysiology behind chronic fatigue and CFS remains largely unknown, preventing development of prophylactic measures as well as therapeutic strategies. Immunological mechanisms have been intensively researched, but results are inconclusive. Findings across some studies include attenuated natural killer (NK) cell function [6] , and low-grade systemic inflammation [7, 8] ; however, these findings are not consistent [9] . Plasma cytokine levels tend to be similar between CFS patients and healthy controls, at least in the adolescent group [10] . Recently, functional alterations of cytotoxic T-cells (CD8 + ) as well as a gene expression pattern suggesting altered B cell differentiation and survival have been reported [11, 12] .
In addition, adolescent CFS is associated with altered autonomic cardiovascular control characterized by enhanced sympathetic and attenuated parasympathetic cardiovascular nervous activity [3, 13] , increased plasma catecholamine levels [3] , and -in some studiesattenuation of the hypothalamus-pituitary-adrenal axis (HPA-axis) [14] . Neuropsychological studies suggest slight impairments of executive control functions [15, 16] ; furthermore, pressure pain threshold is reduced [17] , and CFS patients experience more sleep difficulties than healthy individuals [18] .
Infectious mononucleosis (IM) is a well-known trigger of chronic fatigue and CFS [19] ; among adolescents, 11-13% are reported to have CFS six months after IM [19, 20] . Acute Epstein-Barr virus (EBV) infection is the most common causative agent of IM [21] . Clinical symptoms include fever, pharyngitis, lymphadenopathy, malaise and spleen enlargement, whereas laboratory findings are characterized by elevated liver function test, increased number of cytotoxic T cells (CD8 + ), and altered B cell functions [21] . Thus, acute EBV infection parallels some of the characteristics of CFS. In addition, EBV-infection is associated with other serious long-term complications, such as certain malignancies (e.g. nasopharyngeal carcinoma) and the neurological disease multiple sclerosis [21] .
Previous prospective studies report female sex to be a main predictive factor of chronic fatigue after IM [22] [23] [24] . Other reported predictors include symptom load of the initial infection [19] , days spent in bed following acute IM [25] , autonomic symptoms [25] , illness perception [23] , premorbid mood disorders [24] , days from symptoms to diagnosis [24] , negative life events, and the level of family support [22] . Taken together, previous findings appear somewhat inconsistent, which might be due to heterogeneous patient materials.
Furthermore, well-known biological characteristics of CFS and EBV infection have hardly been explored as predictors, suggesting that a broader approach is warranted.
The problem of heterogeneity might be overcome by studying adolescents exclusively, possibly reducing confounding effects of normal ageing processes and comorbidities as compared to adults. Furthermore, an extensive biopsychosocial approach would ensure that a broad range of possible predictors are covered. These considerations underlie the project entitled Chronic Fatigue Following Acute EBV Infection in Adolescents (CEBA) (cf.
Supplementary Material for details). The primary aim of the present study within the CEBA project was to investigate predictors of chronic fatigue six months after an acute EBV infection. We hypothesized the most important predictors to be a combination of viral load, immune response characteristics, and some of the previously described neuroendocrine features of CFS patients.
Materials and methods

Study design
The CEBA project encompasses a prospective, a cross-sectional and a randomized controlled design with a total follow-up time of 21 months (suppFigure 1). In this paper, prospective results from the first six months are reported; data from a healthy control group are included for reference. The project has been approved by the Norwegian National Committee for Ethics in Medical research. Participation was based upon informed consent. Healthy adolescents having the same distribution of sex and age as the EBV infected individuals were recruited during the same time period, mainly by asking adolescent already included in the EBV group to bring a healthy friend of the same age and sex to the six months follow-up encounter. In addition, a total of ten healthy adolescents were recruited from local schools. This healthy control group was mainly intended for cross-sectional comparison with the subgroup of fatigued EBV individuals at six months follow-up; these comparisons are not reported in the present paper.
Participants
Investigational program
Participants were summoned to a one-day investigational program at the CEBA study center, Akershus University Hospital, Norway. Encounters with the EBV-infected individuals were scheduled as soon as possible after debut of symptoms (baseline), with a follow-up visit six months later (suppFigure 1). Healthy controls were seen only once.
All participants met at 8 a.m. after fasting overnight. They brought morning spot urine in a sterile container, and were instructed to apply a local anesthetic ointment (EMLA®, AstraZeneca) on both antecubital areas one hour before arriving. The investigational program included a clinical examination, ultrasound of the spleen, blood and throat swab sampling, autonomic cardiovascular control assessment, pressure pain threshold assessment, cognitive testing and questionnaire charting, and was followed by activity monitoring (cf.
Supplementary Material for details). The program was carried out in a fixed sequence for all participants by two researchers only (MP and TTA).
Laboratory assays
After at least ten minutes of supine rest, blood samples were obtained in a fixed sequence from antecubital venous puncture performed between 8:30 and 9:00. Samples were assayed for neuroendocrinological, immunological, microbiological, and routine clinical markers. A throat swab sample was assayed for EBV virus load.
Autonomic cardiovascular control
Three test conditions were applied to each participant in a fixed sequence: 1) Supine rest for five minutes; 2) Supine rest with controlled breathing for five minutes; 3) Active upright standing without support for three minutes. The Task Force Monitor (Model 3040i, CNSystems Medizintechnik, Graz, Austria) was used to provide continuous, beat-to-beat, non-invasive recording of blood pressure, heart rate and stroke volume. Other cardiovascular variables of relevance, such as total peripheral resistance index and heart rate variability (HRV) indices were calculated from these primary recordings.
Pressure pain threshold
Pressure pain threshold was assessed by gradually applying increasing pressure to six predefined areas, using the Commander™ Algometer (JTECH Medical, Midvale, USA).
Cognitive testing
A neuropsychological test battery assessed working memory (digit span forward and backward), processing speed, cognitive inhibition, and cognitive flexibility (color-word interference test), verbal learning (total immediate recall), and verbal memory (delayed recall and delayed recognition). In addition, estimated full-scale intelligence quotient (IQ) was assessed.
Questionnaires
The 
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Activity monitoring
Daily physical activity was monitored during seven consecutive days using the activPAL accelerometer device.
Statistical analysis
The CFQ total score at six months was predefined as the primary dependent variable in the prospective analyses. Adherence to case definitions of unspecific chronic fatigue [26] , CFS according to the Fukuda-criteria [27] , and CFS according to the Canada-criteria at six months follow-up [28] , respectively, were set as secondary dependent variables. We estimated that a total of 200 EBV infected individuals would give a power of at least 80 % for detecting a predictor variable that explains 5% of the variance in CFQ total score at six months.
Correspondingly, when assessing associations with a binary predictor at a 5% significance level, a total of 200 patients would give a power of 80% to detect a mean difference of 0.4 SD between the two categories. Assuming a standard deviation of 5 on the CFQ score, this corresponds to a mean difference of approximately 2. Thus, the study was considered to have sufficient power to detect small to medium effect sizes. Furthermore, we estimated that about 70 EBV infected individuals would be classified as fatigue cases at six months follow-up [19] ; recruitment of an equal number of healthy controls was regarded sufficient for detecting cross-sectional differences of clinical relevance, in line with previous studies from our group [7, 10, 15, 17] .
All statistical analyses were carried out using SPSS statistical software (IBM SPSS Statistic 22 Inc., Chicago, IL, USA). Missing values were replaced by multiple imputation. The primary analyses featured simple linear regression between CFQ total score and a total of 149 possible baseline predictors, the selection of which was based on previous research findings in CFS and IM as well as theoretical considerations. The bivariate analyses were followed by multiple linear regression modelling assessing each variable's p-value and the effect on the dependent variable variance (adjusted R 2 , cf. Supplementary Material for details). In the final models, a p-value < 0.05 was considered statistically significant. Binary logistic regression was used for the case-definition analysis.
Results
A total of 895 adolescents with a serological pattern suggesting acute EBV infection were assessed for eligibility ( Figure 1) . A total of 200 were included; they were younger (mean age 16.9 vs 17.5, p<0.001) and the percentage of females was higher (64.5% vs 54.7%, p=0.013)
as compared to the non-included group. The EBV serology patterns did not differ.
A total of 70 healthy controls were also included. Background characteristics did not differ significantly between patients and controls ( Table 1, In the final multiple linear regression model, a total of seven baseline variables were identified as predictors of fatigue score at six months (Table 2) : Sensory sensitivity, pain severity, steps/day, anxiety and elevated plasma CRP at baseline, which were all strongly associated in simple regression analyses, remained predictors in the multivariate model; in addition, correct word recognition performance (an index of verbal memory) were positively associated and plasma vitamin B 12 negatively associated with fatigue.
Applying a less strict procedure for explanatory variable selection (cf. suppFigure 2, point g), two immune biomarkers at baseline (T cell (CD3 + ) fraction and IgM memory B cell subset)
could be considered to have some independent predictive value of fatigue score at six months in addition to the seven baseline variables already identified (suppTable 3). Analyses stratified by sex seemed to indicate differences between males and females, although no interaction term remained statistically significant in the adjusted model. Among males, only baseline anxiety score remained a significant predictor of fatigue at six months, and the explanatory power of the model was much lower than in females (suppTable 3).
In unadjusted logistic regression analyses, a total of 38 baseline variables were associated with either chronic fatigue caseness, CFS according to the Fukuda criteria, or CFS according to the Canada criteria at six months (suppTable 4). In general, the associated variables and the direction of association were similar to the prediction models for fatigue score. For each variable, the odds Ratio (OR) estimates were similar across all three case definitions.
Discussion
The main finding of this study is that fatigue six months after acute EBV infection is significantly and independently predicted by baseline clinical symptoms, functional impairments, negative emotions, verbal memory, plasma CRP and plasma vitamin B 12 . Our finding of symptoms (sensory sensitivity, pain severity), functional impairments (steps/day) and negative emotions (anxiety) as predictors of fatigue are in line with previous research [19, 22, 25] . In particular, high comorbidity with anxiety and depressive disorders are well described in the adolescent CFS literature [29] .
The weak predictive value of baseline biological markers such as viral load and immune response characteristics counteracts our initial hypothesis; plasma CRP being a notable exception. Low-grade systemic inflammation has been reported as a CFS characteristic in adults [8] as well as adolescents [7] . Also, plasma CRP levels are prospectively associated with fatigue in young adults [30] ; however, this is the first study to suggest such an association in adolescents. Intriguingly, on average, baseline CRP levels were significantly lower in the acute EBV infection group as compared to healthy controls (suppTable 2); this finding corroborates a report of attenuated inflammation response in the weeks succeeding the initial phase of infectious mononucleosis [31] . Thus, the slightly raised CRP levels that increase risk of fatigue development in certain individuals seem most likely to be related to other factors than the infection per se; one possibility is the well-described subtle inflammatory enhancement caused by negative life events [32] . Also, the predictive value of plasma vitamin B 12 is a novel finding, although a relationship to fatigue has been suggested from some previous studies [33, 34] .
Finally, to the best of our knowledge, a positive association between verbal memory (as assessed by correct word recognition) and fatigue development has not been reported previously. This finding seems to support a theory of unconscious learning processes (such as Pavlovnian conditioning) underlying chronic fatigue development [35] (cf. below); of note, recent evidence suggest that declarative memory (of which verbal recognition is an example) impacts on conditioning [36] . Of note, the correct word recognition test was the only cognitive test scored poorer by the acute EBV infection group than the healthy control group, (suppTable 2), corroborating previous findings of attenuated cognitive functioning in infectious mononucleosis [37] and suggesting complex interrelations between infection, cognition, fatigue development and possibly other factors. These interrelations deserve attention in further studies.
There was a striking similarity between baseline predictors for six month chronic fatigue caseness, CFS according to the Fukuda-criteria and CFS according to the Canada-criteria. In particular, no pattern of a stepwise progression in the strength of predictor association across the different case definitions could be identified. This is in line with previous findings questioning the discriminating validity of the different CFS case definitions and suggesting similar underlying disease mechanisms [38, 39] . It might be more appropriate to regard fatigue as a continuously distributed variable in the population [1] , with chronic fatigue and CFS denoting the upper tail.
A consistent finding in previous studies is that female sex predicts fatigue development after acute IM [22] [23] [24] . In the present study, female sex was associated with six months fatigue in unadjusted analyses, but not in the final multiple regression model (suppTable 2, Table 2 ). A more detailed exploration of the dataset revealed that sex interacted significantly with several variables, such as baseline perfectionism, illness perception, emotional awareness, insulin like growth factor-1, quality of life, and physical activity, which were significantly associated with six months fatigue among females only (results not shown). Likewise, the multiple regression analysis had much better explanatory power in females than in males; among the latter, only anxiety score was identified as a statistically significant predictor (suppTable 3). This discrepancy might partly be explained by the lower number of males than females, reducing the statistical power of the multiple regression model; still, sex differences in post-EBV chronic fatigue development are suggested.
Taken together, the findings of the present study seem to support a biopsychosocial rather than a biomedical perspective on development of chronic fatigue and CFS. All though speculative, the independent prospective predictions of clinical symptoms, functional impairments, negative emotions, verbal memory, and biomarkers may fit with theories suggesting that chronic fatigue might develop due to unconscious learning processes in which a wide range of interoceptive and exteroceptive stimuli become associated with the fatigue experience [35] . Attempts to validate such theories might be appropriate aims for further research. Accordingly, the present findings suggest that some factors related to chronic fatigue development, such as functional impairments and negative emotions, might be malleable and a target for prophylactic interventions. This, too, should be addressed in further research, taking into account the possibly different trajectories of fatigue development among males and females.
Strengths and limitations
Strengths of the present study include a large group of EBV-infected adolescents recruited soon after debut of IM, few dropouts, and a comprehensive assessment of possible baseline prediction variables. A limitation is limited knowledge of background variables; ideally, the cohort should have been recruited prior to the infectious event, but this strategy would have demanded a much larger number of participants and was not practically feasible. The baseline examination was executed on average one month after the first symptoms of infection; while this time lag is shorter than in comparable studies [20] , it would have been beneficial to have had the baseline examination even closer to the initial infectious episode. The large number of baseline variables compared to the number of participants demanded grouping of the variables prior to the multiple regression modelling; even though this grouping was used as a starting point only, it may have affected the results. Of note, the final multiple regression models only explained about one third of the variance in six months fatigue, suggesting that non-charted variables -ranging from genetic markers to family dynamics -might have important impact, and calling for cautious interpretation of the results. As relatively few individuals in the EBV infected group adhered to case definitions of CFS at 6 months follow-up, a multiple logistic regression analysis featuring CFS caseness as dependent variable was not statistically feasible. Finally, included EBV-infected individuals differed in age and sex distribution from the eligible, non-included group, raising a concern for selection bias.
Conclusion
In adolescents with acute EBV infection, fatigue after six months is predicted by baseline clinical symptoms, functional impairments, negative emotions, verbal memory, plasma CRP and plasma vitamin B 12 . Thus, development of fatigue is to a larger extent predicted by baseline variables related to symptoms and functions than to baseline variables reflecting infectious and immune processes. The principal investigator (VBBW) had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis, and had final responsibility for the decision to submit it for publication. No one of the authors has any conflicts of interests relevant to this study.
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